JFL Life — 360° view

JFL Life, a company in the Pharmaceuticals industry, reported revenue of ₹99 crore and net profit of ₹4.23 crore for the September 2026 quarter.

JFL Life (NSE: JFLLIFE-SM) closed at ₹12.35 on 20 Nov 2026, up 0.4% over the past year. Its market capitalisation is ₹41 crore and it trades at 4.5 times earnings.

Share price
₹12.35 (20 Nov 2026)
Market cap
₹41 Cr (20 Nov 2026)
P/E
4.52 (20 Nov 2026)
Revenue
₹99 Cr (September 2026 quarter)
Net profit
₹4 Cr (September 2026 quarter)
ROCE
18.2% (FY26)
ROE
15.0% (FY26)
Book value
₹15.5 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹14.70 / ₹8.55 (20 Nov 2026)
1-year return
0.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: JFLLIFE-SM

Incorporated in 2010, JFL Life Sciences Ltd produces and markets a wide range of formulations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.